Radiation Therapy and the Natural History of Childhood Cancers
NCT00064883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241
Last updated 2020-05-04
Summary
This study will: 1) provide standard non-experimental radiation therapy to children who have a form of cancer or similar disease process that is of scientific interest, importance, or educational value; 2) determine the effects of radiation on childhood cancers; and 3) allow for the education of nurses, medical students, residents, clinical fellows, and physicians in the management and care of this specialized group of cancer patients. Patients in this study will not receive experimental therapy, but will be given standard medical care.
Patients eligible for this study include: 1) children with cancer or a precancer syndrome, such as aplastic anemia or other myelodysplastic syndrome, who are between 3 years and 21 years of age and whose disease will be treated or has been treated with radiation therapy in the NCI's Radiation Oncology Branch (ROB); 2) patients with cancer or a precancer syndrome who have disease manifestations of special interest to ROB investigators; and 3) patients with cancer or a precancer syndrome who offer an important educational benefit to radiation oncology trainees and staff.
Participants will undergo a medical history, physical examination, and blood tests, and radiation therapy. Before beginning treatment, medical information such as pathology reports, laboratory results, diagnosis and treatment history, scan results, and so forth, will be obtained from the patient's medical records. Additional procedures that may need to be done include scans, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), lung function tests, arteriogram, or tumor biopsies.
Participants will then have a (simulation) treatment planning session for radiation therapy during which measurements are taken, CT images are taken, and markings are placed on the body to help determine the treatment area. The radiation will be delivered to the body by a machine called a linear accelerator, which produces x-rays. Radiation therapy is generally given once or twice a day 5 days a week. Each treatment takes about 10 minutes.
When the course of treatment is completed, patients return to the Radiation Oncology clinic for follow-up visits that include blood tests, a physical examination, and review of symptoms, if any. Visits are kept to a minimum, but continue for a prolonged period to watch for any late effects of treatment that may occur over a period of decades.
Conditions
- Cancer
- Childhood Malignancy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Kevin A Camphausen, M.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 3 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-28
- Primary Completion
- 2019-07-25
- Completion
- 2020-05-01
Countries
- United States
Study Locations
More Related Trials
-
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
NCT00634231 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
NCT00002875 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004010 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
NCT00001686 ·Status: COMPLETED
-
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
NCT01175356 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
NCT00042367 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
NCT00017225 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma
NCT00002802 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective-perspective Observational Cohort Study on Toxicity and Efficacy of Radiotherapy in Pediatric and Adult Patients With Pediatric Histology Treated at the Pediatric Radiotherapy of the CRO in Aviano
NCT06639165 ·Status: RECRUITING
-
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
NCT00084838 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS
NCT00003859 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
NCT00392327 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
NCT04479514 ·Status: COMPLETED ·Phase: PHASE2
-
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
NCT00410631 ·Status: UNKNOWN ·Phase: PHASE3
-
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
NCT03126916 ·Status: RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
NCT00281905 ·Status: UNKNOWN ·Phase: PHASE2
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
NCT00006480 ·Status: COMPLETED ·Phase: PHASE1
-
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
NCT00165139 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
NCT00006258 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma
NCT01440283 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002704 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma
NCT00031590 ·Status: TERMINATED ·Phase: PHASE2
-
Short Course Radiotherapy
NCT07147179 ·Status: RECRUITING ·Phase: NA